Home›Acetazolamide›Acetazolamide + Levothyroxine Sodium

Does Acetazolamide Interact with Levothyroxine Sodium?

The levothyroxine label lists sulfonamides among drugs that may decrease thyroid hormone secretion. It does not name acetazolamide. This class statement does not establish the acetazolamide-specific association in CDI.

Label evidence and limitations

Specific-drug mapping not established. The stored moderate classification and specific-drug mapping require review. An unconfirmed mapping is not evidence that the combination is safe.

Product scope: Oral levothyroxine sodium tablets; a thyroid-secretion class statement.

Read the DailyMed label: Levothyroxine Sodium Tablets, USP
Section: Drug Interactions — Drugs that alter thyroid hormone secretion. Compared version 3, label date 2020-03-01. The linked label may be updated after this comparison.

This comparison uses the label identifier saved with the CDI record. The compared version may be newer than the original extraction.

AI-assisted source comparison dated 2026-10-16. This is a comparison of label text, not independent clinical review or an individual safety assessment. CDI's stored severity category is not an FDA-assigned rating. Confirm your exact medicines and formulations with your pharmacist or prescriber before changing treatment.

Stored CDI classification
Moderate
Acetazolamide Class
Carbonic Anhydrase Inhibitor
Management
Confirm exact products with your pharmacist
Data Source
Product label via NLM DailyMed

What To Tell Your Doctor or Pharmacist

If you are taking Acetazolamide and your doctor is considering prescribing Levothyroxine Sodium (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Never stop or change either medication without first consulting your healthcare provider
💊 Acetazolamide+💊 Levothyroxine Sodium(Tirosint Sol)

Severity & Interaction Details

🟡
Stored CDI classification: moderate
Specific-drug mapping not established
The stored moderate classification and specific-drug mapping require review. An unconfirmed mapping is not evidence that the combination is safe.
Stored CDI scale
MinorContra
On record
Yes
Drug A class
Carbonic Anhydrase Inhibitor
Drug B class
—
Source
NLP:levothyroxine sodium

How to interpret this source comparison

The stored moderate classification and specific-drug mapping require review. An unconfirmed mapping is not evidence that the combination is safe.

About Acetazolamide and Levothyroxine Sodium

Acetazolamide is a Carbonic Anhydrase Inhibitor. Levothyroxine Sodium is also sold under the brand name Tirosint Sol. Levothyroxine Sodium additionally carries an FDA boxed warning, the FDA's strongest safety alert.

Source and Limitations

This record was produced by automated extraction from drug-label information, including AI processing. The summary and mechanism are not verbatim FDA quotations. The drug profiles below may describe different formulations from the source label. Confirm the exact product and route with your pharmacist. This page does not establish independent clinical review.

📖 Source: NLP:levothyroxine sodium

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Acetazolamide and Levothyroxine Sodium against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
How this information is prepared: CDI uses automated extraction, including AI, to summarize drug labeling from openFDA and includes separately identified curated-reference records. RxNorm helps identify medications; it does not verify interaction claims. Extracted summaries and CDI severity classifications can contain errors and are not verbatim FDA statements or independent clinical review. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.

CDI: source-linked explanations